Danijela Bokanovic
Graz, Austria
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 23 publications
Patients with or without a clonal mast cell disease undergoing venom immunotherapy differ in their CD8 T memory cell response.
Journal: The Journal of investigative dermatology
Published: December 22, 2025
A Safe and Efficient 7-Week Immunotherapy Protocol With Aluminum Hydroxide Adsorbed Bee Venom.
Journal: Allergy
Published: January 21, 2025
Metabolomic and Lipidomic Alterations in Patients with Atopic Dermatitis with Dupilumab-Associated Ocular Surface Disease.
Journal: JID innovations : skin science from molecules to population health
Published: August 13, 2024
Persistent Neutrophil Infiltration and Unique Ocular Surface Microbiome Typify Dupilumab-Associated Conjunctivitis in Patients with Atopic Dermatitis.
Journal: Ophthalmology science
Published: March 03, 2023
Erythema in genital areas
Journal: Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete
Published: November 27, 2020
Simultaneous up-dosing of bee and vespid venom immunotherapy is safe.
Journal: Allergy
Published: August 21, 2019
A safe and efficient 7-week immunotherapy protocol with aluminum hydroxide adsorbed vespid venom.
Journal: Allergy
Published: August 09, 2019
Possible utility of basophil activation test in dual honeybee and vespid sensitization.
Journal: The journal of allergy and clinical immunology. In practice
Published: April 03, 2019
Immunological differences between insect venom-allergic patients with and without immunotherapy and asymptomatically sensitized subjects.
Journal: Allergy
Published: November 17, 2017
Erratum to: Allergen immunotherapy for insect venom allergy: protocol for a systematic review.
Journal: Clinical and translational allergy
Published: August 24, 2017
Last Updated: 09/26/2026